Xylem Inc. (NYSE:XYL) Receives $153.31 Average Price Target from Analysts

Xylem Inc. (NYSE:XYL) has been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $153.1538.

A number of equities analysts recently issued reports on the stock. Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Stifel Nicolaus dropped their price target on shares of Xylem from $159.00 to $157.00 and set a “buy” rating on the stock in a research report on Monday. Barclays reduced their price target on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and increased their price objective for the company from $130.00 to $140.00 in a report on Thursday, June 25th. Finally, UBS Group raised their price objective on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th.

Xylem Trading Up 2.4%

Shares of XYL stock opened at $119.66 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem has a 1 year low of $105.29 and a 1 year high of $154.27. The stock has a fifty day moving average of $114.04 and a two-hundred day moving average of $122.82. The firm has a market capitalization of $28.44 billion, a PE ratio of 29.77, a price-to-earnings-growth ratio of 1.66 and a beta of 1.03.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.11 billion. During the same quarter in the prior year, the business posted $1.03 earnings per share. The company’s revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, research analysts expect that Xylem will post 5.52 EPS for the current year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Thursday, May 28th. Xylem’s dividend payout ratio (DPR) is presently 42.79%.

Insiders Place Their Bets

In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction dated Monday, May 4th. The stock was purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Company insiders own 0.32% of the company’s stock.

Institutional Investors Weigh In On Xylem

Hedge funds and other institutional investors have recently bought and sold shares of the business. J. Stern & Co. LLP lifted its holdings in Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock valued at $6,189,132,000 after acquiring an additional 45,082,435 shares during the last quarter. Norges Bank acquired a new position in shares of Xylem in the 4th quarter worth approximately $361,012,000. SEB Asset Management AB acquired a new position in shares of Xylem in the 1st quarter worth approximately $66,700,000. Balyasny Asset Management L.P. raised its holdings in shares of Xylem by 346.2% in the 3rd quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after purchasing an additional 553,152 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. bought a new stake in shares of Xylem in the 2nd quarter worth approximately $64,407,000. 87.96% of the stock is currently owned by institutional investors.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.